SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

SeaStar Medical Holding Corp
Date: May 30, 2025 · CIK: 0001831868 · Accession: 0000000000-25-005737

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
May 30, 2025
Author
Division of
Form
UPLOAD
Company
SeaStar Medical Holding Corp

Letter

Re: SeaStar Medical Holding Corp Draft Registration Statement on Form S-1 Submitted May 27, 2025 CIK No. 0001831868 Dear Eric Schlorff:

May 30, 2025

Eric Schlorff Chief Executive Officer SeaStar Medical Holding Corp 3513 Brighton Blvd, Suite 410 Denver, CO 80216

This is to advise you that we do not intend to review your registration statement.

We request that you publicly file your registration statement at least two business days prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Nicholas O'Leary at 202-551-4451 with any questions.

Sincerely,
Division of
Corporation Finance
Office of
Industrial Applications and
Services
cc: Josh Erekson, Esq.

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 May 30, 2025

Eric Schlorff
Chief Executive Officer
SeaStar Medical Holding Corp
3513 Brighton Blvd, Suite 410
Denver, CO 80216

 Re: SeaStar Medical Holding Corp
 Draft Registration Statement on Form S-1
 Submitted May 27, 2025
 CIK No. 0001831868
Dear Eric Schlorff:

 This is to advise you that we do not intend to review your registration
statement.

 We request that you publicly file your registration statement at least
two business
days prior to the requested effective date and time. Please refer to Rules 460
and 461
regarding requests for acceleration. We remind you that the company and its
management are
responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review,
comments, action or absence of action by the staff.

 Please contact Nicholas O'Leary at 202-551-4451 with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of
Industrial Applications and
 Services
cc: Josh Erekson, Esq.
</TEXT>
</DOCUMENT>